Low Molecular Weight Heparin After Mechanical Heart Valve Replacement
- 14 March 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 101 (10) , 1083-1086
- https://doi.org/10.1161/01.cir.101.10.1083
Abstract
Background—Patients with mechanical heart valves require life-long anticoagulation. We report here the first large and comparative series of consecutive patients anticoagulated with low molecular w...Keywords
This publication has 8 references indexed in Scilit:
- Subcutaneous Enoxaparin for Outpatient Anticoagulation Therapy in a Patient with an Aortic Valve ReplacementPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1998
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Dose-Ranging Trial of Enoxaparin for Unstable Angina: Results of TIMI 11AJournal of the American College of Cardiology, 1997
- Long-Term Anticoagulation of Outpatients with Adverse Events to Oral Anticoagulants Using Low-Molecular-Weight HeparinSeminars in Thrombosis and Hemostasis, 1997
- Low Molecular Weight Heparin for Thromboprophylaxis during Pregnancy in 2 Patients with Mechanical Mitral Valve ReplacementThrombosis and Haemostasis, 1996
- Acute massive postoperative atrial thrombosis in a patient undergoing low molecular weight heparin anticoagulationJournal of Cardiothoracic and Vascular Anesthesia, 1993
- Subcutaneous Heparin Treatment of Deep Venous Thrombosis: A Comparison of Unfractionated and Low Molecular Weight HeparinPathophysiology of Haemostasis and Thrombosis, 1986